Adjuvant chemotherapy and outcomes in patients with nodal and resection margin‐negative pancreatic ductal adenocarcinoma: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Adjuvant chemotherapy and outcomes in patients with nodal and resection margin‐negative pancreatic ductal adenocarcinoma: A systematic review and meta‐analysis

Published:2019-03-05 Issue:7 Volume:119 Page:932-940
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Flaum Nicola¹^ORCID,Hubner Richard A.¹,Valle Juan W.¹²,Amir Eitan³,McNamara Mairéad G.¹²

Affiliation:

1. Department of Medical OncologyThe Christie NHS Foundation TrustManchester UK

2. Division of Cancer SciencesUniversity of ManchesterManchester UK

3. Department of Medical OncologyPrincess Margaret Cancer Centre and University of TorontoToronto Canada

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.25440

Reference41 articles.

1. SEER. SEER Cancer Statistics Review 1975‐2015: Cancer of the Pancreas (Invasive) (online). Accessed on January 1 2018. Available at:https://seer.cancer.gov/csr/1975_2014/results_merged/sect_22_pancreas.pdf. Accessed November 4 2017.

2. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database11No competing interests declared.

3. Resected adenocarcinoma of the pancreas?616 patients: results, outcomes, and prognostic indicators

4. Pancreatic Cancer

5. A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Therapy After Upfront Resection of Resectable Pancreatic Cancer: Patterns of Omission and Use—A Prospective Real-Life Study;Annals of Surgical Oncology;2024-01-29

2. Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery;Diagnostics;2023-02-09

3. Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data;Neoplasia;2022-12

4. Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment;The Journal of Pathology;2022-05-05

5. Risk Evaluation of EMT and Inflammation in Metastatic Pancreatic Cancer Cells Following Plasma Treatment;Frontiers in Physics;2020-10-09